Iron glycinate, also called ferrous bisglycinate chelate, is a form of supplemental iron in which an iron atom is bonded to two molecules of the amino acid glycine. That chelated structure keeps the iron stable as it passes through the stomach and into the small intestine, which is why it tends to be absorbed more efficiently and cause fewer gut complaints than conventional iron salts like ferrous sulfate. The form has gained popularity in supplements and prenatal vitamins, but the real-world advantages over older iron forms are more nuanced than marketing copy suggests.
How Iron Glycinate Differs From Other Iron Supplements
Most iron supplements on pharmacy shelves contain inorganic iron salts: ferrous sulfate, ferrous fumarate, or ferrous gluconate. These are cheap and effective, but the free iron ions they release in the gut can irritate the stomach lining and react with food components, which is why so many people quit their iron pills before finishing a course. Iron glycinate sidesteps some of that by wrapping the iron in glycine. The resulting molecule is small, with a molecular weight of roughly 204 daltons, compared to iron polymaltose complexes that can weigh tens of thousands of daltons.1Bentham Open Access. Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial That compact size matters because the chelate can travel through the gut largely intact, shielding the iron from binding to dietary inhibitors like phytates and tannins until it reaches the cells lining the intestine.
You will see the terms “iron glycinate,” “ferrous bisglycinate,” “ferrous bisglycinate chelate,” and “iron bis-glycinate” used interchangeably. They all refer to the same compound. Supplement labels sometimes use “chelated iron” loosely, so checking for the specific bisglycinate form on the ingredient list is the only reliable way to know what you are getting.
How It Gets Absorbed
The absorption story is the main reason iron glycinate generates interest. Conventional ferrous sulfate releases free iron ions in the stomach, and those ions enter intestinal cells primarily through a channel called DMT1. Research in human intestinal cell models has shown that iron from ferrous bisglycinate also uses DMT1 as its main entry route, much like ferrous sulfate does.2PubMed Central. Iron Transport from Ferrous Bisglycinate and Ferrous Sulfate in DMT1-Knockout Human Intestinal Caco-2 Cells But there is an additional twist: the glycine shell allows the chelate to also be taken up through peptide transporters, the channels that normally ferry small protein fragments into cells. Work in pig intestinal cells found that ferrous bisglycinate increased the expression of both DMT1 and the peptide transporter PepT1, suggesting it has more than one way in.3Journal of Animal and Feed Sciences. Ferrous bisglycinate increased iron transportation through DMT1 and PepT1 in pig intestinal epithelial cells compared with ferrous sulphate
This dual-pathway entry partly explains the bioavailability numbers. Food fortification studies have found that ferrous glycinate chelate can be roughly two-and-a-half to three-and-a-half times more bioavailable than ferrous sulfate, with fewer gut symptoms.4PubMed. Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients The glycine shell also provides partial protection against common dietary inhibitors of iron absorption. Phytates in whole grains, polyphenols in tea, and calcium in dairy products can all bind free iron and drag it out of the body unabsorbed. Iron from bisglycinate is still affected by these inhibitors, but to a lesser degree than ferrous sulfate.5PubMed. Iron amino acid chelates That reduced sensitivity to food interactions is a practical advantage, because it means the supplement does not need to be taken on a completely empty stomach to work well.
What the Clinical Trials Actually Show
Higher bioavailability in a lab dish does not always translate to better real-world outcomes, so the clinical picture matters. Across different populations, the evidence is encouraging but uneven.
In infants and young children with iron-deficiency anemia, a trial comparing ferrous bisglycinate chelate to ferrous sulfate found that both groups had significant hemoglobin increases, but only the bisglycinate group also showed significant rises in ferritin, the protein that stores iron for later use. The researchers calculated apparent iron bioavailability at about 91% for the chelate versus 27% for ferrous sulfate.6PubMed. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate A separate trial in children found that bisglycinate raised hemoglobin by about 3.85 g/dL compared to 3.13 g/dL with ferrous sulfate, with fewer gastrointestinal side effects in the bisglycinate group.7Pakistan Journal of Health Sciences. Efficacy of Ferrous Bis-Glycinate versus Ferrous Sulphate in Children with Iron Deficiency Anemia
In pregnant women, a randomized trial found that ferrous bisglycinate with folinic acid produced numerically larger improvements in hemoglobin, ferritin, and transferrin saturation at three and six months compared to standard ferrous fumarate, while also producing significantly fewer reports of nausea, abdominal pain, bloating, constipation, and metallic taste.8PubMed Central. Efficacy and Safety of Ferrous Bisglycinate and Folinic Acid in the Control of Iron Deficiency in Pregnant Women: A Randomized, Controlled Trial A review of pregnancy supplementation data concluded that iron glycinate chelate at 15 to 25 mg per day was better tolerated and more effective for treating iron deficiency than ferrous sulfate at 40 to 50 mg per day.9Nutrition Reviews. Safety and efficacy of supplements in pregnancy Being able to get the same or better results with a lower elemental iron dose is a real win during pregnancy, when nausea is already a daily battle for many women.
The evidence is less clear-cut when you zoom out to larger analyses. A systematic review and meta-analysis of randomized controlled trials found that while bisglycinate supplementation showed potential for modest ferritin increases in adults, the results were uncertain, and no significant differences in hemoglobin or ferritin were detected among children when studies were pooled together.10PubMed Central. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials That does not mean bisglycinate does not work in children; individual trials do show benefits. It means the pooled data is too noisy, with different doses, durations, and starting iron levels across studies, to draw a confident group-level conclusion yet. An interesting finding from a Mexican schoolchildren trial adds some nuance: one week after supplementation ended, there was no difference in ferritin between the bisglycinate and sulfate groups, but six months later the bisglycinate group had higher ferritin, suggesting the chelate form may be better at building up iron stores that persist over time.11PubMed Central. Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: a randomized controlled trial
The Tolerability Advantage
For many people, the biggest selling point of iron glycinate is not that it works better, but that it is easier to keep taking. Conventional iron supplements are notorious for causing constipation, nausea, stomach cramps, and dark stools. These side effects drive a huge number of people to stop taking their iron before their deficiency is corrected, which makes even the most potent supplement useless in practice.
A study comparing the three most common iron forms at doses designed to prevent iron deficiency during pregnancy found that ferrous bisglycinate at 25 mg of elemental iron per day produced significantly fewer gastrointestinal complaints than either ferrous fumarate at 40 mg or ferrous sulfate at 50 mg.12PubMed Central. Low-Dose Prophylactic Oral Iron Supplementation in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints Part of that gap comes from the lower dose needed, but the chelated structure also plays a role by reducing the amount of free iron floating around in the gut to cause irritation. In cancer patients with mild iron deficiency, a comparison of bisglycinate chelate and ferrous sulfate at conventional doses found similar efficacy, with gastrointestinal side effects about half as common in the bisglycinate group.13PubMed. Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate
A large real-world evaluation of pregnant women taking ferrous bisglycinate found that nearly 98% reported no adverse events at all, with the remaining fraction describing only mild gut symptoms. Over 93% rated tolerability as very good or good, and more than 98% stuck with more than 80% of their prescribed treatment.14International journal of reproduction, contraception, obstetrics and gynecology. Real-world evaluation of safety and effectiveness of ferrous bis-glycinate and its combination in pregnant women with iron deficiency anemia Those compliance numbers are strikingly high for oral iron, and compliance is ultimately what determines whether a supplement actually corrects a deficiency.
Safety Profile
Formal toxicology testing in animals has been reassuring. A safety evaluation in rats found no biologically or statistically significant differences between control animals and those fed ferrous bisglycinate at doses up to 500 mg per kilogram of body weight per day across measures of body weight, food consumption, blood chemistry, organ weights, and tissue examination under the microscope. The researchers set the no-observed-adverse-effect level at 500 mg per kilogram per day, the highest dose tested.15PubMed. Safety evaluation of ferrous bisglycinate chelate That is a very large margin above any supplemental dose a human would take. The compound is classified as Generally Recognized as Safe (GRAS) for food fortification in the United States.
One concern with any highly absorbable iron form is the risk of overdoing it, particularly in people who do not actually have a deficiency. Iron is unusual among minerals in that the body has no efficient way to excrete excess amounts. That is why iron overload conditions like hereditary hemochromatosis can be dangerous. Healthy people who take iron supplements without a documented need can accumulate iron over time, and high body iron stores have been loosely associated with oxidative stress. Because bisglycinate is better absorbed than regular ferrous sulfate, the risk of inadvertently overshooting your iron needs is at least theoretically higher if you are supplementing without monitoring. Getting your ferritin levels checked before and during supplementation is a reasonable precaution. A pilot trial found a significant correlation between lower starting hemoglobin levels and greater ferritin increases in the bisglycinate group, suggesting the body regulated its own iron uptake based on need.1Bentham Open Access. Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial That built-in regulation is reassuring, but it is not a substitute for knowing your baseline levels.
Iron Glycinate for Athletes
Iron deficiency without outright anemia is common in female athletes, driven by menstrual losses, foot-strike hemolysis from running, and sometimes inadequate dietary intake. It can cause fatigue and impaired performance even when hemoglobin levels look normal, because the body’s iron stores, measured by ferritin, are depleted. A study in NCAA Division 1 female athletes compared daily versus three-times-weekly dosing of iron (using ferrous bisglycinate) for treating this non-anemic iron deficiency. The daily regimen produced an average ferritin increase of about 12.9 micrograms per liter, while the three-times-weekly regimen raised ferritin by about 5.2 micrograms per liter, and both increases were statistically significant.16PubMed. Daily versus three times weekly dosing for treatment of iron deficiency nonanemia in NCAA Division 1 female athletes The daily approach was clearly more effective, but the fact that even alternate-day dosing moved the needle is encouraging for athletes who struggle with daily supplementation.
Some sports nutrition guidelines now recommend ferrous bisglycinate as a first-line oral option for athletes specifically because the better tolerability profile means fewer training days disrupted by stomach problems. An athlete who cannot train because their iron pills give them cramps is worse off than one taking a slightly less absorbable form that they actually tolerate.
The Food Fortification Problem
If iron glycinate absorbs so well and causes fewer side effects, you might wonder why it has not replaced ferrous sulfate in fortified foods like flour and cereal. The answer is mostly about chemistry and taste. Ferrous bisglycinate is reactive. In dairy products, it easily oxidizes to its ferric form, which causes off-color development and accelerates fat oxidation. A sensory study found that yogurt fortified with ferrous bisglycinate scored the lowest in flavor and appearance acceptability because panelists described the resulting product as unpleasantly grayish.17Journal of Nutrition Health & Food Science. Iron Fortification of Yogurt and Pasteurized Milk In maize porridge, bisglycinate produced the most rancidity among the iron forms tested and lowered both sensory quality and storage stability.18Journal of Food Science. Sensory Quality and Lipid Oxidation of Maize Porridge as Affected by Iron Amino Acid Chelates and EDTA
Heat adds another layer of difficulty. Ferrous bisglycinate powder has low thermal stability because the ferrous ions oxidize when heated, which limits its use in foods that are cooked or baked before consumption.19Food Hydrocolloids. Thermal stability and in vitro digestion of alginate–starch–iron beads for oral delivery of iron Researchers have experimented with encapsulating bisglycinate in solid lipid nanoparticles and alginate-starch beads to protect it from oxidation during food processing and also from dietary inhibitors during digestion.20Food Science and Technology Research. Estimation of the Iron Absorption from Ferrous Glycinate-loaded Solid Lipid Nanoparticles by Rat Everted Intestinal Sac Model These are promising lab-stage solutions, but they add cost and complexity that make them impractical for mass fortification in low-income settings where iron deficiency is most prevalent. For now, ferrous sulfate and electrolytic iron remain the default fortification choices precisely because they are cheap and shelf-stable, even though they are less well absorbed.
Effects on Gut Bacteria
Unabsorbed iron that reaches the colon can feed certain bacteria, and there has been concern that iron supplementation might shift the gut microbial balance in unhelpful ways. A secondary analysis of a double-blind randomized trial in Cambodian women of reproductive age found that iron supplementation overall did not alter gut microbial diversity. However, ferrous bisglycinate specifically increased the relative abundance of Enterobacteriaceae, a bacterial family that includes some potential pathogens, and there was a trend toward more Escherichia-Shigella species. Interestingly, ferrous sulfate was the form associated with an increase in a virulence gene linked to enteropathogenic E. coli, not bisglycinate.21PubMed Central. The Effect of Oral Iron Supplementation on Gut Microbial Composition: a Secondary Analysis of a Double-Blind, Randomized Controlled Trial among Cambodian Women of Reproductive Age
These findings are early and come from a single trial in women who were predominantly iron-replete to begin with, not the most typical supplementation scenario. The clinical relevance of a modest shift in Enterobacteriaceae in otherwise healthy women is unclear. But it does reinforce the general principle that supplemental iron of any form should be taken because you need it, not as a blanket wellness practice. Iron-replete individuals who take iron supplements are exposing their colons to unneeded unabsorbed iron, and whatever the form, that is not a free lunch for gut health.
When Bisglycinate Is Not the Best Choice
Iron glycinate has real advantages, but it is not the right call in every scenario. Severe iron-deficiency anemia often requires intravenous iron, because no oral supplement, regardless of how well absorbed, can replenish stores quickly enough when hemoglobin has dropped dangerously low. People with inflammatory bowel disease or active gut inflammation may absorb oral iron poorly and have their symptoms worsened by any form of oral iron, though bisglycinate’s gentler profile might still be preferable to sulfate if oral therapy is attempted.
Cost is another practical consideration. Ferrous sulfate is among the cheapest medications in existence, often pennies per dose. Ferrous bisglycinate supplements typically cost several times more. For public health programs treating iron deficiency across large populations, that cost difference matters. A pediatric comparison trial noted that while bisglycinate improved iron markers more effectively than lactoferrin alone, it also produced more side effects than lactoferrin, suggesting that gentler options exist for children who are particularly sensitive.22PubMed. Comparing oral iron bisglycinate chelate, lactoferrin, lactoferrin with iron and iron polymaltose complex in the treatment of children with iron deficiency anemia The landscape of iron supplementation has more players than just sulfate and bisglycinate, and the best option depends on the individual’s severity of deficiency, tolerance for side effects, and budget.
People with hemochromatosis or other iron-loading conditions should avoid iron glycinate entirely. Its enhanced absorption is the last thing someone needs when their body is already accumulating too much iron. And anyone taking iron alongside medications that interact with divalent metals, like certain antibiotics or thyroid hormones, should still space their doses apart, since the chelated form does not fully eliminate these interactions.